title: Mitomycin C adsorbed on activated carbon particles: is intraperitoneal chemotherapy effective for synchronous pleuritis carcinomatosa?
authors.forename: T
authors.initials: T
authors.lastname: Yokota
authors.forename: A
authors.initials: A
authors.lastname: Hagiwara
authors.forename: K
authors.initials: K
authors.lastname: Sawai
authors.forename: T
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: M
authors.initials: M
authors.lastname: Shimotsuma
authors.forename: T
authors.initials: T
authors.lastname: Sasabe
authors.forename: T
authors.initials: T
authors.lastname: Ohyama
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007725:Krukenberg Tumor / Q000150:complications* / Q000601:surgery; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage*; D010051:Ovarian Neoplasms / Q000150:complications* / Q000601:surgery; D014677:Pharmaceutical Vehicles; D010998:Pleurisy / Q000188:drug therapy* / Q000209:etiology
chemical_list: D008937:Mitomycins; D014677:Pharmaceutical Vehicles; D016685:Mitomycin